PROPANC BIOPHARMA, INC.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
Asset Breakdown FY2020
Total Assets: $98.5K
Liabilities Breakdown FY2020
Total Liabilities: $3.7M
Asset Breakdown
Total Assets: $98.5K
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $67.0K | 68.0% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $5.7K | 5.8% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $25.8K | 26.2% |
Liabilities Breakdown
Total Liabilities: $3.7M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $842.2K | 22.5% |
| Long-Term Debt | $1.6M | 41.7% |
| Other Liabilities | $1.3M | 35.8% |